Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Hong Kong · Delayed Price · Currency is HKD 33.74
-0.42 (-1.23%)
May 19, 2026, 1:05 PM HKT
HKG:3692 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 5,555 | 4,372 | 3,278 | 2,584 | 2,713 |
Depreciation & Amortization | 393.02 | 401.35 | 366.38 | 344.6 | 278.47 |
Loss (Gain) From Sale of Assets | -4.3 | -5.72 | -2.1 | -11.24 | -3.94 |
Asset Writedown & Restructuring Costs | - | 31.98 | - | - | - |
Loss (Gain) From Sale of Investments | 16.71 | -61.27 | -158.22 | -67.58 | -26.28 |
Loss (Gain) on Equity Investments | - | - | 2.12 | 13.86 | - |
Stock-Based Compensation | 143.27 | 137.73 | 171.37 | 179.42 | 65.47 |
Provision & Write-off of Bad Debts | -0.83 | -18.18 | 22.38 | 7.15 | 0.82 |
Other Operating Activities | -912.65 | -1,032 | -820.19 | -2.96 | -22.01 |
Change in Accounts Receivable | 110.08 | 62.67 | 341.76 | 90.45 | -549.35 |
Change in Inventory | 20.93 | -86.73 | -129.54 | -40.94 | -111.75 |
Change in Accounts Payable | 116.46 | 54.09 | -58.53 | -26.03 | 123.95 |
Change in Unearned Revenue | 1,162 | -19.24 | 13.37 | 2.9 | -173.49 |
Change in Other Net Operating Assets | 137.85 | 25.38 | 90.17 | -332.15 | 282.26 |
Operating Cash Flow | 6,738 | 3,862 | 3,116 | 2,741 | 2,577 |
Operating Cash Flow Growth | 74.46% | 23.93% | 13.69% | 6.37% | 7.80% |
Capital Expenditures | -356.43 | -221.96 | -219.6 | -272.82 | -460.03 |
Sale of Property, Plant & Equipment | 27.26 | 23.96 | 10.96 | 21.1 | 54.77 |
Sale (Purchase) of Intangibles | -133.03 | -302.97 | -142.93 | -19 | -15.16 |
Investment in Securities | -7,902 | -1,988 | 647.54 | -5,846 | -2,095 |
Other Investing Activities | 1,210 | 1,097 | 778 | 181.17 | 256.75 |
Investing Cash Flow | -7,155 | -1,392 | 1,074 | -5,935 | -2,259 |
Short-Term Debt Issued | - | 500 | 900 | - | - |
Long-Term Debt Issued | - | - | - | - | 3,877 |
Total Debt Issued | - | 500 | 900 | - | 3,877 |
Short-Term Debt Repaid | - | -500 | -900 | - | - |
Long-Term Debt Repaid | -22.38 | -4,204 | -18.96 | -42.49 | -12.29 |
Total Debt Repaid | -22.38 | -4,704 | -918.96 | -42.49 | -12.29 |
Net Debt Issued (Repaid) | -22.38 | -4,204 | -18.96 | -42.49 | 3,865 |
Issuance of Common Stock | 3,589 | 33.19 | 37.99 | 13.14 | 15.11 |
Repurchase of Common Stock | - | -33.69 | -114.87 | -76.62 | -57.97 |
Common Dividends Paid | -2,012 | -1,858 | -652.08 | -712.18 | -380.87 |
Other Financing Activities | - | -3.21 | -5.77 | - | -24.23 |
Financing Cash Flow | 1,554 | -6,066 | -753.7 | -818.14 | 3,417 |
Foreign Exchange Rate Adjustments | -51.58 | -62.43 | -122.36 | -40.57 | -79.29 |
Net Cash Flow | 1,086 | -3,658 | 3,314 | -4,053 | 3,655 |
Free Cash Flow | 6,382 | 3,640 | 2,897 | 2,468 | 2,117 |
Free Cash Flow Growth | 75.31% | 25.67% | 17.36% | 16.60% | 119.88% |
Free Cash Flow Margin | 42.47% | 29.69% | 28.67% | 26.31% | 21.31% |
Free Cash Flow Per Share | 1.07 | 0.61 | 0.48 | 0.42 | 0.35 |
Cash Interest Paid | - | 3.21 | 5.77 | - | - |
Cash Income Tax Paid | 910.59 | 807.17 | 589.58 | 324.03 | 319.44 |
Levered Free Cash Flow | 5,162 | 2,401 | 2,069 | 1,453 | 1,256 |
Unlevered Free Cash Flow | 5,163 | 2,405 | 2,111 | 1,489 | 1,289 |
Change in Working Capital | 1,548 | 36.16 | 257.23 | -305.78 | -428.38 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.